Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RSV maternal immunization planning study
PACTR202406762571290Completed
- Sponsor
- Wits Vaccines and Infectious Diseases Analytics Research Unit
- Start
- Jul 2024
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
Open-label, single-arm trial of RSVpreF vaccine in respiratory syncytial virus disease (RSV), sponsored by Wits Vaccines and Infectious Diseases Analytics Research Unit. Started Jul 2024; status: completed.
02
Drugs
RSVpreF vaccine
03
Conditions
respiratory syncytial virus disease (RSV)
Beyond the preview
Go deeper on PACTR202406762571290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202406762571290.